>

Innovative nebulisation delivery of GalNAc conjugated siRNAa potential route for systemic drug delivery through the lungs

Innovative nebulisation delivery of GalNAc conjugated siRNAa potential route for systemic drug delivery through the lungs

100%
Attach a PDF file or paste a PDF link in the component settings.

Sign up for our latest news and updates

By signing up you agree to our privacy policy.

© 2026 Acu-Flow Limited (trading as Nebu-Flow®) Registered number: SC624449

Sign up for our latest news and updates

By signing up you agree to our privacy policy.

© 2026 Acu-Flow Limited (trading as Nebu-Flow®) Registered number: SC624449

Sign up for our latest news and updates

By signing up you agree to our privacy policy.

© 2026 Acu-Flow Limited (trading as Nebu-Flow®) Registered number: SC624449

Sign up for our latest news and updates

By signing up you agree to our privacy policy.

© 2026 Acu-Flow Limited (trading as Nebu-Flow®) Registered number: SC624449